Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Glenn P. Muir currently holds 36,622 shares of G1 Therapeutics, Inc. (GTHX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Glenn P. Muir has been a net seller of GTHX stock. They have purchased $2.2M and sold $27.1M worth of shares.
Glenn P. Muir's most recent insider trade was on Dec 16, 2025, when they sold 3,366 shares at $26.12 per share.
Glenn P. Muir serves as Executive at G1 Therapeutics, Inc. (GTHX). They have executed 135 insider transactions totaling $29.4M over their tenure at the company.
Glenn P. Muir holds the position of Executive at G1 Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Glenn P. Muir has shown a selling trading pattern, with $2.2M in total purchases and $27.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Glenn P. Muir was on May 6, 2014, when they sold $2.4M worth of HOLX shares. This transaction involved 100,000 shares at $23.58 per share.
Glenn P. Muir currently owns 36,622 shares of G1 Therapeutics, Inc. (GTHX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Glenn P. Muir's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Glenn P. Muir has 135 Form 4 filings on record as an insider at G1 Therapeutics, Inc..
Set alerts for Glenn P. Muir and 40,000+ other insiders.